Browsing Category

Supplier News

156 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

From DCAT Week: Kindeva Drug Delivery and Meridian Medical Technologies Merge To Create New Drug–Device CDMO 
By

By
A new drug–device CDMO, which merged Kindeva Drug Delivery (formerly 3M Drug Delivery Systems), a CDMO of drug-delivery services, and Meridian Medical Technologies, a Saint Louis, Michigan-based CDMO of autoinjectors,…

From DCAT Week: Porton Pharma Solutions Expanding Drug-Substance and Drug-Product Capacity 
By

By
Porton Pharma Solutions, a CDMO of active pharmaceutical ingredients (APIs) and drug products, is heavily investing in its drug-substance and drug-product research and manufacturing capacities. This includes expansions to current…

From DCAT Week: Thermo Fisher Scientific Outlines Multi-Segment Expansions 
By

By
Thermo Fisher Scientific is proceeding with a series of investments to expand capacity in cell and gene therapies, drug products, and biomanufacturing. Leon Wyszkowski, President of Commercial Operations, Pharma Services,…

From DCAT Week: WuXi Biologics’ Growing Global Footprint 
By

By
WuXi Biologics, a contract research, development, and manufacturing organization (CRDMO), continues to enhance its global manufacturing network by increasing its global capacity to meet growing clients needs around the world.…

From DCAT Week: Siegfried Expands Drug-Product and Small-Molecule API Capacity 
By

By
Siegfried, a CDMO of active pharmaceutical ingredients (APIs) and drug products, recently invested $190 million to expand its footprint in small-molecule and biopharmaceutical fill–finish capacity and capabilities. Marianne Späne, Executive…

From DCAT Week: INCOG BioPharma Services Plans Additional Filling Capacity for Injectables 
By

By
INCOG BioPharma Services, a Fisher, Indiana-based CDMO specializing in sterile injectables, is increasing injectable drug-product filling capacity at is site in Indiana. Cory Lewis, President and CEO, INCOG BioPharma Services,…

From DCAT Week 2023: Granules Investing $250 M for New Green Small-Molecule API Mfg Facility
By

By
Granules India, a Hyderabad, India-based pharmaceutical manufacturing company of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosage forms, is investing in a new $250-million manufacturing facility for key…

From DCAT Week: Lonza Outlines Expansions in Drug Products, ADCs, mRNA. Products, Lipid Nanoparticles 
By

By
Lonza has announced a series of investment to increase development and manufacturing capacity for drug products, antibody-drug conjugates, mRNA products and lipid nanoparticles as well as increasing early-stage capabilities. Jean-Christophe…

From DCAT Week 2023: WuXi STA Outlines Major Expansion Plans 
By

By
WuXi STA, a subsidiary of WuXi AppTec, is proceeding with a major expansion plan in its global R&D and manufacturing network for small-molecule active pharmaceutical ingredients (APIs), oligonucleotides, peptides, and…

From DCAT Week 2023: Samsung Biologics Investing $1.5 Bn for New Biomanufacturing Facility 
By

By
Samsung Biologics, a CDMO of biologics, is investing KRW 1.9 trillion ($1.46 billion) for a new biomanufacturing facility in South Korea, which will be the first plant of the company’s…